• Über Taylor Wessing
  • Unsere Anwälte
  • Expertise
    • Branchen
        • Technologie-, Medien & Kommunikation
        • Private Wealth
        • Real Estate, Infrastructure & Energy
        • Life Sciences & Healthcare
        • Aerospace & Defence
        • Automobilindustrie & Mobilität
        • Business & Professional Services
        • Chemieindustrie
        • Konsumgüter und Einzelhandel
        • Bank- & Finanzwesen
        • Hotels, Hospitality & Leisure
        • Logistik & Transport
        • Industrieunternehmen
        • Öffentlicher Sektor
    • Rechtsgebiete
        • Künstliche Intelligenz
        • Bank- & Finanzrecht
        • Marken & Werbung
        • Handels- & Vertriebsrecht
        • Kartell-, Vergabe-, Beihilfe- und Außenhandelsrecht
        • Urheber- und Medienrecht
        • Wirtschaftsstrafrecht und Compliance
        • M&A / Gesellschaftsrecht & Kapitalmarktrecht
        • Daten & Cybersicherheit
        • Disputes & Investigations
        • Arbeitsrecht
        • Umwelt, Planung & Regulierung
        • Environmental, Social & Governance (ESG)
        • Intellectual property
        • Informationstechnologie
        • Patents Technology & Life Sciences
        • Private Client
        • Private Equity
        • Projects, Energy & Infrastructure
        • Immobilienrecht
        • Regulation
        • Restrukturierung & Insolvenzrecht
        • Steuerrecht
        • Venture Capital
  • International
    • Europa
        • Standorte
        • Österreich
        • Belgien
        • Tschechische Republik
        • Frankreich
        • Deutschland
        • Ungarn
        • Italy
        • Niederlande
        • Polen
        • Portugal
        • Republik Irland
        • Slowakei
        • Spanien
        • Großbritannien
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German Group
        • Unsere Büros
    • Naher Osten & Afrika
        • Standorte
        • Naher Osten
        • Vereinigte Arabische Emirate
          Groups
        • Africa Group
        • Israel Group
        • Unsere Büros
    • Amerika
        • Standorte
        • Latein Amerika
        • USA
          Groups
        • Brazil Group
        • Unsere Büros
    • Asien
        • Standorte
        • Asien
        • China
        • Südkorea
          Groups
        • India Group
        • Japan Group
        • Unsere Büros
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • EU-Whistleblower-Richtlinie (HinSchG)
        • Lieferkettengesetz
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: Digitales Tech-Magazin
        • Podcasts
        • Synapse
        • Alle Insights
    • Events
        • In Präsenz
        • Online
        • Alle Events
    • News
        • Media Center
        • Unternehmensmeldungen
        • Deal Meldungen
        • Alle News
  • Karriere
  • DE
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • Team
  • Jules Fabre
Jules Fabre
Jules Fabre

Jules Fabre

Taylor Wessing

Partner

  • Paris Frankreich
+33 1 72 74 03 33
vCard
E-Mail Call me
Featured award

Legal 500 Europe, Middle East and Africa, 2026

Healthcare life sciences - ‘They are exceptional lawyers in terms of their legal expertise, and their ability to work effectively and productively in larger teams, and interact effectively and commercially with clients. A great team to work with.’ ‘A highly motivated team which can do in-depth research into topics really quickly, understands clients' requests fast and provides a lot of experience as well.’ ‘Jules Fabre is an excellent strategist and has the ability to manage the progress of large and complex litigation projects while being familiar with the detail of key technical and legal aspects of the dispute. He is also very personable and a pleasure to work alongside.’ ‘Jules Fabre has excellent knowledge of the framework not only of IP and general law but also EU law and pharmaceutical legislation and regulation, as well as business acumen.’ ‘Jules Fabre, Marina Jonon and Louise Millot provided excellent knowledge of the local laws and practice, with a very strong technical background and outstanding strategic and communication skills.’

Scroll to featured award

Jules Fabre heads Taylor Wessing's patent department in Paris. He specialises in intellectual property, with a particular focus on patent and regulatory matters in the Life Sciences and pharmaceutical sector.

He has extensive experience handling complex French and cross border patent and SPC litigations, both in private practice and in­house and is often instructed by clients to handle the pan-European co-ordination of their patent litigations and market access strategies, in addition to representing them before French courts and the UPC. Jules was involved in the first ever branded versus generic patent litigation brought before the UPC.

ln addition to his previous experience in other international law firms (Hogan Lovells, Linklaters, Pinsent Masons), Jules was a Senior Counsel in the European IP and Regulatory Litigation team of a Teva Pharmaceuticals in London, where he coordinated pan-European launch strategies, patent litigations and settlements. This brings an in-depth understanding of the industry from the inside, which enables Jules to provide sound and commercially relevant advice, and a detailed knowledge of patent litigation in the various European jurisdictions.

Jules is Unified Patent Court (UPC) representative.

Expertise

Rechtsgebiete und Gruppen

Patents Technology & Life Sciences
Beilegung von Patent- & Know-how-Streitigkeiten
Erstellung & Verhandlung von Patent- & Know-how-Verträgen

Branchen

Automobilindustrie & Mobilität
Industrieunternehmen
Chemieindustrie
Life Sciences & Healthcare

Patent Perspective Quick Listens

A UPC and European patent litigation podcast.

Listen now

CV

Since 2025 Partner, Taylor Wessing
2023 - 2025 Partner, Pinsent Masons
2019 - 2023 Counsel, Pinsent Masons
2017 - 2019 Senior Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals in London
2014 – 2017 Senior Associate, Linklaters
2011 – 2014 Associate, Hogan Lovells
2012 Admitted to the Bar, Paris
2008 Master II Droit de la Propriété Intellectuelle, Concurrence, Distribution et Commerce, Centre d’Études Internationales de la Propriété Intellectuelle (Strasbourg)

Karriere

Since 2025 Partner, Taylor Wessing
2023 - 2025 Partner, Pinsent Masons
2019 - 2023 Counsel, Pinsent Masons
2017 - 2019 Senior Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals in London
2014 – 2017 Senior Associate, Linklaters
2011 – 2014 Associate, Hogan Lovells

Ausbildung

2012 Admitted to the Bar, Paris
2008 Master II Droit de la Propriété Intellectuelle, Concurrence, Distribution et Commerce, Centre d’Études Internationales de la Propriété Intellectuelle (Strasbourg)

Fremdsprachen

English

Awards

Legal 500 Europe, Middle East and Africa, 2026

Featured

Healthcare life sciences - ‘They are exceptional lawyers in terms of their legal expertise, and their ability to work effectively and productively in larger teams, and interact effectively and commercially with clients. A great team to work with.’ ‘A highly motivated team which can do in-depth research into topics really quickly, understands clients' requests fast and provides a lot of experience as well.’ ‘Jules Fabre is an excellent strategist and has the ability to manage the progress of large and complex litigation projects while being familiar with the detail of key technical and legal aspects of the dispute. He is also very personable and a pleasure to work alongside.’ ‘Jules Fabre has excellent knowledge of the framework not only of IP and general law but also EU law and pharmaceutical legislation and regulation, as well as business acumen.’ ‘Jules Fabre, Marina Jonon and Louise Millot provided excellent knowledge of the local laws and practice, with a very strong technical background and outstanding strategic and communication skills.’

Legal 500 Europe, Middle East and Africa, 2026

Intellectual Property: Patents - ‘Highly adept patent litigation team who routinely and successfully handles highly complex patent litigation projects. They are highly knowledgable, strategic thinkers and a pleasure to work with.’ ‘Jules Fabre is a great leader and an exceptional lawyer. He has the ability to rapidly grasp highly complex aspects of patent disputes and effectively manage his team. He is also a valued and productive member of larger teams working on multi-jurisdictional projects. Would highly recommend.’

IAM Patent 1000 2025

Silver Individuals : Litigation - "Jules is a genius from a legal and strategic standpoint. He can take on critical and complicated litigation projects, demonstrating his high level of organisation, diligence and ability to be on top of every detail in the case. Jules has a great understanding of the technical aspects as well as the law, and utilises this to provide excellent insight, tactical advice and superb advocacy. He is totally unpretentious, approachable, amiable and an overall joy to work with."

IP Stars 2025

Patent Star

Mehr

Pharma/Life Sciences: Intellectual Property - "He is a brilliant intellectual property lawyer. I have learnt so much from him. He is really a great person and is assisting clients with a lot of care and oversight."

Intellectual Property: Patents - "Jules is proficient and very good, with a good technical background. He is absolutely outstanding and has a deep knowledge of the French system, the law and the practice."

Recommended individuals - “very happy with his work, he is a rising star”

News & Insights: Jules Fabre

Zu den Insights
Klicken Sie hier für Details
UPC

Security for Costs before the Unified Patent Court (UPC) Current Case Law and Strategic Implications

7. November 2025

von mehreren Autoren

Glass.Mapper.Sc.Fields.Image?.Alt
Patents Technology & Life Sciences

Preliminary injunctions in France

22. Oktober 2025
Briefing

von mehreren Autoren

Klicken Sie hier für Details
Open podcast
Patent Perspectives Quick Listens

Episode 10 - Marking the second anniversary of the UPC

In episode ten of Patent Perspectives, Paul England is joined by Amanda Ebbutt, Christian Dekoninck, Jules Fabre and Phillip Rektorschek.

9. Juni 2025

von mehreren Autoren

English

1 von 10 Podcasts

Klicken Sie hier für Details
Zu den Insights

Aktuelle News & Insights

Aktuelle BGH-Entscheidungen: Telemedizin im Fokus – Was bedeutet das für digitale Gesundheitsangebote?

27. März 2026
Briefing

von mehreren Autoren

Klicken Sie hier für Details

Update aus Berlin: Bundestag beschließt Gesetz zur Beschleunigung der Anerkennungsverfahren ausländischer Berufsqualifikationen in Heilberufen

27. März 2026
Briefing

von Kathleen Munstermann-Senff, LL.M. (Medizinrecht) und Rica Nauschütte, LL.M. (Medizinrecht)

Klicken Sie hier für Details

Payback-Punkte beim Hörgerätekauf: Bundesgerichtshof schafft Klarheit bei Wertgrenzen für „geringwertige Kleinigkeiten“ im Bereich der Medizinprodukte

27. März 2026
Briefing

von Dr. Daniel Tietjen und Ennio Schwind, LL.M. Eur.

Klicken Sie hier für Details
Open Source Software & Compliance

Strategisches Management von Open Source im Automotive — Rechtliche Rahmenbedingungen und Compliance-Anforderungen

26. März 2026
Briefing

von Thomas Kahl und Nils von Reith

Klicken Sie hier für Details
M&A / Gesellschaftsrecht und Kapitalmarktrecht

More Than Share and Asset Deals: Innovative Transaction Structures for MedTech Companies

25. März 2026
Briefing

von Christopher Peine

Klicken Sie hier für Details
Life Sciences & Healthcare

Advising on Tropic Biosciences' US$105 million Series C financing

25. März 2026

von mehreren Autoren

Klicken Sie hier für Details
UPC

Proportionality considerations in proceedings before the UPC

19. März 2026
Briefing

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

Newsflash: LAG Niedersachsen kippt starre 30 Minuten „am Patienten“-Vorgabe in der Rufbereitschaft

17. März 2026
Briefing

von Kathleen Munstermann-Senff, LL.M. (Medizinrecht) und Jonas Warnken

Klicken Sie hier für Details
Life Sciences & Healthcare

Newsflash: Sektorenübergreifende Versorgungseinrichtungen – Was ist erlaubt und was nicht?

11. März 2026
Briefing

von Dr. Martin Jäger

Klicken Sie hier für Details
M&A / Gesellschaftsrecht und Kapitalmarktrecht

Taylor Wessing berät Wuxi Lead Intelligent bei Börsengang in Hongkong in Höhe von 630 Millionen US-Dollar

10. März 2026

von Qun Huang, lic. iur. und Songjiwen (Harry) Wu

Klicken Sie hier für Details
Mehr

Weitere Beraterinnen und Berater

Frankreich
/Taylor Wessing/Images/People/Profiles/France/Jonon-Marina/Jonon-Marina-wit

Marina Jonon

Counsel

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
/Taylor Wessing/Images/People/Profiles/France/Millot-Louise/Millot-Louise-wit

Louise Millot

Associate

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
Clémence de Marassé-Enouf

Clémence de Marassé-Enouf

Associate

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
Lucile Cheneau

Lucile Cheneau

Associate

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen

Roxane Soyez

Associate

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
Alle Beraterinnen und Berater

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.

Alle Events
Newsletter-Anmeldung
  • Über Taylor Wessing
  • Campaigns and online tools
  • News
  • Unsere Anwälte
  • Expertise
  • International
  • Insights
  • Events
  • Presse & News
  • Kontakt
  • Karriere
  • Alumni
  • Datenschutzhinweise
  • Datenschutzbestimmungen & Cookie Hinweise
  • Rechtliche und regulatorische Informationen
  • Regulatorische Informationen zu Kosten
  • Beschwerdeverfahren für Mandanten
  • Nutzungsbedingungen
  • Anti-slavery Statement
  • Nachhaltigkeit
  • Scam E-Mails

© Taylor Wessing